As a leader in Lynch syndrome diagnostics, Lynsight is committed to fostering a company culture based on innovation, collaboration and excellence at every level.
Our team is passionate about improving patient outcomes and is always on the lookout for individuals who share our dedication.
Head of Culture & Communication
Philippe brings a wealth of experience from international corporate roles in major blue-chip companies in Europe and the Americas. At Lynsight he is responsible for organizational development, company culture, employee engagement, internal & external communications.
Philippe Arnez
, MSc
Head of Culture & Communication
Administrative Specialist
Maria has several years of experience working in administration in international companies. She is responsible for Lynsight’s office administration and related functions and works with the leadership team in various projects.
Maria Korkala
, BHM, BBA
Administrative Specialist
Research Nurse
Tuija is an integral part of our sample collection working from the Jorvi hospital in Espoo. She has a long and diverse background in nursing and currently works as a research nurse in cancer research projects. Her experience and people skills are highly appreciated in recruiting participants, taking samples and organizing sample operations.
Tuija Vanhatalo
Research Nurse
Laboratory Technician
Uupa is an experienced allrounder in the laboratory field. She is responsible for Lynsight’s equipment maintenance and sterilization and its further development. Uupa also enjoys assisting other laboratory processes and frequently participates in cell culture and its supportive functions.
Uupa Tassberg
Laboratory Technician
R&D Specialist
Mikael focuses on cell culture and protein-based laboratory functions, while participating in various R&D projects. Prior to joining the team, he studied the effects of decreased MLH1 expression on gene expression and cellular functions.
Mikael Kyriacou
, MSc
R&D Specialist
R&D Specialist
Tea works closely with MMR proteins and their functional DiagMMR testing. She has broad methodological expertise from sample culturing to testing and actively participates in various R&D projects. In her Master’s thesis she investigated the ability to quantify DiagMMR based DNA repair using different techniques. Before joining Lynsight, she investigated how red and processed meat play a part in increasing the risk of colorectal cancer.
Tea Kuivala
, MSc
R&D Specialist
Senior R&D Specialist
Maria did her PhD thesis on orexin receptor signaling and has since worked in different projects gaining experience in, for example, cellular disease models. At Lynsight she participates in and leads R&D projects, with emphasis on the DiagMMR performance and the development of DiagMMR testing conditions.
Maria Jäntti
, PhD
Senior R&D Specialist
Quality Manager
Jaana is responsible for the quality management at Lynsight, the regulatory compliancy of DiagMMR and she is also involved in assisting in all steps of DiagMMR testing and R&D. She studied cell communication in her PhD and has vast experience in cell culture and other laboratory processes that support her ability to ensure the meticulous handling of patient samples from sampling to testing through her unique quality-oriented perspective.
Jaana Putula
, PhD
Quality Manager
Chief Scientific Officer
Minttu has worked on Lynch syndrome research for over 10 years and is a co-inventor of DiagMMR. Her doctoral thesis, “Recognizing Lynch syndrome by DNA mismatch repair deficiency” focused on the functional detection of reduced mismatch repair and the pathogenicity assessment of found LS variants. She is responsible for the laboratory operations, scientific research and product development at Lynsight.
Minttu Kansikas
, PhD
Chief Scientific Officer
GI Oncologist and Cancer Geneticist
Dr. Hall is a reputable medical oncologist and scientist in cancer, focusing on hereditary cancer risk for gastrointestinal cancers. KOLs in the field of Lynch syndrome.
Michael Hall
, MD, MS
GI Oncologist and Cancer Geneticist
Clinical Professor, Genetic Counselor
KOL in the United States for Lynch syndrome screening, testing protocols, and referral guidelines for cancer genetics. Internationally-recognized cancer genetic counselor.
Heather Hampel
, MS, CGC
Clinical Professor, Genetic Counselor
Founder & Chairman of the Board
Minna is the leading inventor of DiagMMR with more than 30 years of experience in the field of Lynch syndrome research. She has had an active role in both the identification of the LS-related genes and mutations, as well as the improvement of LS recognition with more than 70 scientific publications in the field. Minna is also an active member of the International Society for Gastrointestinal Hereditary Tumors, InSiGHT.
Prof. Minna Nyström
, PhD
Founder & Chairman of the Board
Chief Executive Officer
Niklas is responsible for operational and financial management, investor relations, and shareholder management at Lynsight. He is a corporate finance professional with a background in M&A and capital restructurings. Niklas joined Lynsight in 2017 as the CFO and was appointed as CEO in 2022.
Niklas Lahti
, MSc
Chief Executive Officer
Lynsight is committed to reducing cancer mortality rates with our simple and accurate diagnostic method for inherited MMR deficiency, DiagMMR.
As a leader in Lynch syndrome diagnostics, Lynsight is committed to fostering a company culture based on innovation, collaboration and excellence at every level.
Our team is passionate about improving patient outcomes and is always on the lookout for individuals who share our dedication.
Lynsight is committed to reducing cancer mortality rates with our simple and accurate diagnostic method for inherited MMR deficiency, DiagMMR.
